Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE 2nd, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non- ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for The Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction). Circulation. 2007;116:e148 e304. 196. Andrus MR, Holloway KP, Clark DB. Use of beta-blockers in patients with COPD. Ann Pharmacother. 2004;38:142 145. 197. Salpeter S, Ormiston T, Salpeter E. Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005:CD003566. 198. Early treatment of unstable angina in the coronary care unit: a ran- domised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both: re- port of the Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) Research Group. Br Heart J. 1986;56:400 413. 199. Verapamil in acute myocardial infarction: the Danish Multicenter Study Group on Verapamil in Myocardial Infarction. Eur Heart J. 1984;5:516 528. 200. Hansen JF. Treatment with verapamil after an acute myocardial in- farction: a review of the Danish Studies on Verapamil in Myocardial Infarction (DAVIT I and II). Drugs. 1991;42(suppl 2):43 53. 201. Hansen JF, Tingsted L, Rasmussen V, Madsen JK, Jespersen CM. Verapamil and angiotensin-converting enzyme inhibitors in patients with coronary artery disease and reduced left ventricular ejection fraction. Am J Cardiol. 1996;77:16D 21D. 202. Braunwald E, Pfeffer MA. Ventricular enlargement and remodeling fol- lowing acute myocardial infarction: mechanisms and management. Am J Cardiol. 1991;68:1D 6D. 203. Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1). Lancet. 1995;345:686 687. 204. 